当前位置:首页 - 行情中心 - 辰光医疗(920300) - 财务分析 - 现金流量表

辰光医疗

(920300)

  

流通市值:6.55亿  总市值:8.46亿
流通股本:6653.17万   总股本:8584.71万

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金51,285,287.9623,700,779.24121,657,573.24100,703,521.58
  收到的税费返还1,798.86--52,969.8
  收到其他与经营活动有关的现金744,509.883,613,373.423,615,137.26612,602.53
  经营活动现金流入小计52,031,596.727,314,152.66125,272,710.5101,369,093.91
  购买商品、接受劳务支付的现金13,658,383.273,663,681.9540,940,901.930,943,507
  支付给职工以及为职工支付的现金24,492,206.1912,126,944.4254,509,363.6341,108,145.95
  支付的各项税费2,678,921.081,906,408.25,137,780.523,171,068.75
  支付其他与经营活动有关的现金9,517,168.496,080,638.5322,752,792.1317,518,134.22
  经营活动现金流出小计50,346,679.0323,777,673.1123,340,838.1892,740,855.92
  经营活动产生的现金流量净额1,684,917.673,536,479.561,931,872.328,628,237.99
二、投资活动产生的现金流量:
  收回投资收到的现金10,000,000-98,000,00088,000,000
  取得投资收益收到的现金41,547.95-253,733.24239,046.87
  处置固定资产、无形资产和其他长期资产收回的现金净额791,000770,000--
  投资活动现金流入小计10,832,547.95770,00098,253,733.2488,239,046.87
  购建固定资产、无形资产和其他长期资产支付的现金1,543,178.641,074,047.018,151,694.021,845,836.59
  投资支付的现金10,000,00010,000,00098,000,00088,000,000
  投资活动现金流出小计11,543,178.6411,074,047.01106,151,694.0289,845,836.59
  投资活动产生的现金流量净额-710,630.69-10,304,047.01-7,897,960.78-1,606,789.72
三、筹资活动产生的现金流量:
  取得借款收到的现金42,000,00014,000,000191,600,00096,000,000
  筹资活动现金流入小计42,000,00014,000,000191,600,00096,000,000
  偿还债务支付的现金63,540,10019,260,100202,069,900100,269,900
  分配股利、利润或偿付利息支付的现金1,560,012.5797,525.263,982,662.793,282,317.09
  支付其他与筹资活动有关的现金24,021-3,309,144.792,251,722.5
  筹资活动现金流出小计65,124,133.520,057,625.26209,361,707.58105,803,939.59
  筹资活动产生的现金流量净额-23,124,133.5-6,057,625.26-17,761,707.58-9,803,939.59
四、汇率变动对现金及现金等价物的影响-74,488.94-45,012.43-33,536.4616,681.48
五、现金及现金等价物净增加额-22,224,335.46-12,870,205.14-23,761,332.5-2,765,809.84
  加:期初现金及现金等价物余额28,767,678.8528,767,678.8552,529,011.3552,529,011.35
  期末现金及现金等价物余额6,543,343.3915,897,473.7128,767,678.8549,763,201.51
补充资料:
  净利润-12,911,802.9--60,440,038.14-
  资产减值准备571,201.89-12,003,233.09-
  固定资产和投资性房地产折旧4,794,392.55-9,957,098.02-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧4,794,392.55-9,957,098.02-
  无形资产摊销1,985,633.11-5,054,110.29-
  长期待摊费用摊销1,037,472.59-2,639,937.93-
  处置固定资产、无形资产和其他长期资产的损失-2,412,626.65--9,666.95-
  固定资产报废损失--20,700-
  财务费用2,028,287.17-4,838,816.38-
  投资损失-41,547.95--253,733.24-
  递延所得税-1,268,983.85-8,722,342.69-
  其中:递延所得税资产减少-1,268,983.85-8,722,342.69-
  存货的减少5,170,719.32--3,321,839.82-
  经营性应收项目的减少-6,787,293.2-22,510,666.82-
  经营性应付项目的增加9,091,225.37--28,531,701.03-
  其他--21,743,538.4-
  不涉及现金收支的投资和筹资活动金额其他项目--0-
  现金的期末余额6,543,343.39-28,767,678.85-
  减:现金的期初余额28,767,678.85-52,529,011.35-
  现金及现金等价物的净增加额-22,224,335.46--23,761,332.5-
公告日期2026-08-262026-04-292026-04-242025-10-30
审计意见(境内)标准无保留意见
TOP↑